longevitywatch

Is retatrutide more effective than Ozempic?

Moderate evidence

Indirect comparisons suggest that retatrutide produces greater weight loss than semaglutide (Ozempic/Wegovy), but the drug has not yet been approved and no direct head-to-head trial exists. If you want to be treated now, semaglutide or tirzepatide are the available choices.

Retatrutide acts on three hormone receptors simultaneously, whereas semaglutide targets only one. In network meta-analyses that compare multiple studies indirectly, retatrutide 12 mg comes out on top among all agents examined: an average weight loss of 22% after 48 weeks compared with placebo. Semaglutide 2.4 mg (sold at a higher dose for obesity as Wegovy) achieves around 14% weight loss in the same comparison. That looks like a substantial difference, but it is important to know that this is an indirect comparison, not a direct head-to-head trial.

There is in fact no study in which people were randomly assigned to either a retatrutide group or a semaglutide group. All claims about 'who wins' come from statistical network comparisons. Such analyses can be distorted by differences in study populations, study duration, and the way outcomes are measured. The certainty about the precise difference is therefore limited.

On top of that, retatrutide is not yet on the market at all. The large phase 3 studies are still ongoing and must confirm long-term safety and efficacy. The available safety data come mainly from a single phase 2 study. The most commonly reported side effects are gastrointestinal complaints such as nausea, vomiting, and diarrhoea. These occurred in 47 to 84% of participants, were predominantly mild, and decreased when the starting dose was lower. Heart rate also rose temporarily, but whether that matters in the long term is still unknown.

If you want to do something about your weight now and qualify for medication, retatrutide is not an option. Semaglutide and tirzepatide are approved and available. Based on the indirect comparisons, tirzepatide (which also acts on two receptors) already appears to be more effective than semaglutide, and retatrutide appears to go beyond that still. But until the phase 3 data are in, that remains a promise, not a certainty.

The evidence
8 studies · 1 randomised trial

All comparisons between retatrutide and semaglutide are based on indirect network meta-analyses (PMID 39305981, 39761578). There are no direct head-to-head RCTs. Safety data for retatrutide come mainly from a single phase 2 study (PMID 37366315). The phase 3 programme (TRIUMPH) is still ongoing (PMID 40563436, 38626998).

Last checked: September 2026 · how this was judged
Related answers

Does orforglipron, the weight-loss pill, work as well as Ozempic?

Orforglipron works well for blood sugar and weight, but in obesity it is probably less powerful than injectable Ozempic and causes side effects more often. If you want to avoid the injection pen it is a serious option, but discuss it with your doctor, because the direct comparison on weight loss is still missing.

Moderate evidence

What are the side effects and risks of retatrutide?

Retatrutide causes gastrointestinal complaints in many users and a temporary increase in heart rate; serious side effects were rare in the available studies, but long-term safety remains largely unknown. Slow dose escalation helps to limit complaints, but always discuss use with your doctor.

Do GLP-1 medications (such as Ozempic) help you age more healthily?

For people with cardiovascular disease, kidney disease, or fatty liver disease, GLP-1 medications offer proven benefits that are also relevant at older ages. As an anti-ageing intervention in healthy people, their use is not yet supported by evidence.

Moderate evidence

Does rapamycin help people live longer in good health?

Rapamycin works in mice, but whether it also leads to a longer and healthier life in humans has not yet been demonstrated. Side effects are real, long-term data in healthy people are absent, and use outside a clinical context cannot currently be justified.

Moderate evidence

Does semaglutide as a pill work just as well as the injection?

For weight loss, the pill (25 mg daily) and the injection (2.4 mg weekly) are comparably effective. If you have diabetes there is more uncertainty; discuss with your doctor which form suits you best.

Yes · Moderate evidence

Is ubiquinol better than regular CoQ10?

Ubiquinol is not automatically better than regular CoQ10: formulation matters more than form. Choose a well-soluble version of either, and bear in mind that the clinical evidence for the benefits of ubiquinol specifically remains limited.

Moderate evidence
Related research
23 Sep
Grip strength tests gene therapy for aging
23 Sep
Novo Nordisk bets on life beyond GLP-1 drugs
22 Sep
Fasting improves symptoms in Huntington’s patients
Don't see your question?
Ask it and we'll look it up for you.
Ask a question →
Newsletter

Stay in the loop

Twice a week, the most important longevity research in your inbox.